NutraMax cites softness in cough/cold market for flat third-quarter sales.
This article was originally published in The Tan Sheet
Executive Summary
NUTRAMAX THIRD-QUARTER SALES DECLINE 1.4% TO $15.2 MIL., reflecting "continued softness" in the cough/cold products market due to a mild winter and slower inventory sell-through at retail, the company said in a July 24 release. Net income for the quarter ended July 1 dropped 27.7% to $857,000, from $1.2 mil. the previous year.